kari Therapeutics announced the appointment of Mark Kubik as Head of Business Development – Oncology.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKTX:
- Akari Therapeutics releases video from newly appointed CEO Gaslightwala
- Akari Therapeutics Advances ADC Development Amid Financial Challenges
- Akari Therapeutics reports FY24 EPS 0c vs 0c last year
- Akari Therapeutics Delays Yearly Financial Report
- Akari Therapeutics Appoints New CEO Abizer Gaslightwala